NCT02718755 2018-06-26
Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies
M.D. Anderson Cancer Center
Phase 2 Withdrawn
Clinical Trials
1 trialsInterventional × Leukemia, Prolymphocytic × asparaginase erwinia chrysanthemi recombinant × Clear all